UK in talks to join EU's coronavirus vaccine scheme – Financial Times
|The United Kingdom (UK) is in talks with the European Union (EU) to join the EU's coronavirus scheme, the Financial Times reported on Friday, citing UK officials familiar with the matter.
Earlier in the day, the European Commission announced that it had granted conditional approval for the use of Gilead Sciences' Remdesivir in COVID-19 treatment.
Market reaction
This headline doesn't seem to be providing a boost to market sentiment. As of writing, the UK's FTSE 100 was down 1.45% on the day at 6,150. Meanwhile, the GBP/USD pair was flat on the day at 1.2468.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.